As of 2024-12-15, the Fair Value of Moberg Pharma AB (publ) (MOB.ST) is -2.38 SEK. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 10.28 SEK, the upside of Moberg Pharma AB (publ) is -123.11%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-06-30 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | 20.02 | 8.80 | 7.49 | -15.71 | -21.09 | -0.10 |
| YoY growth | -96.59% | -56.05% | -14.84% | -309.69% | -34.26% | -102.29% |
| Market Cap (mil) | 492.21 |
| P/E | |
| Forward P/E |
| EPS | -0.48 |
| Avg earnings growth rate | -102.29% |
| TTM earnings | -22.75 |